observational cohort study: Clinical Trials

4 trials of observational cohort study, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 not yet recruiting, 1 terminated. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Terminated 1

Follow observational cohort study: new trials by email Literature Review of observational cohort study trials Research Report on observational cohort study

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clonal Hematopoiesis of Immunological Significance
observational cohort study - Immune System Diseases, Autoimmune Diseases
Not yet recruitingAssistance Publique - Hôpitaux de Paris50002026-04-012026-03-23
Extension Study to Assess Batoclimab in Participants With Thyroid Eye Disease
Observational cohort study, Batoclimab - Thyroid Eye Disease
Phase 3TerminatedImmunovant Sciences GmbH1092022-11-062026-04-29
No Association Between Vitamin C and E Supplementation, Frailty, and Grip Strength Over Five Years: The CoLaus Study
Observational cohort study - Frail Elderly Syndrome
CompletedCentre Hospitalier Universitaire Vaudois27112017-07-012017-08-23
Integrated Discovery and Development of Innovative TB Diagnostics
Observational cohort study - Tuberculosis, Pulmonary
CompletedHarvard University Faculty of Medicine14502015-05-012024-10-03

Conditions studied

Autoimmune Diseases (2)  ·  Disease (1)  ·  Graves Ophthalmopathy (1)  ·  Hematologic Diseases (1)  ·  Immune System Diseases (1)  ·  Inflammation (1)  ·  Leukemia (1)  ·  Leukemia, Myelomonocytic, Juvenile (1)  ·  Lymphoma (1)  ·  Lymphoproliferative Disorders (1)  ·  Monoclonal Gammopathy of Undetermined Significance (1)  ·  Myelodysplastic Syndromes (1)  ·  Myelodysplastic-Myeloproliferative Diseases (1)  ·  Myeloproliferative Disorders (1)  ·  Tuberculosis (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  Centre Hospitalier Universitaire Vaudois (1)  ·  Harvard University Faculty of Medicine (1)  ·  Immunovant Sciences GmbH (1)

Countries

Australia (1)  ·  Belgium (1)  ·  France (1)  ·  Georgia (1)  ·  Hungary (1)  ·  Israel (1)  ·  Italy (1)  ·  Latvia (1)  ·  New Zealand (1)  ·  Poland (1)  ·  Puerto Rico (1)  ·  Slovakia (1)  ·  Spain (1)  ·  Switzerland (1)  ·  United Kingdom (1)

Top investigators

Molly F. Franke, ScD (1)  ·  Peter Vollenweider, MD (1)